Back to Search
Start Over
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia.
- Source :
- Journal of Clinical Oncology; 12/20/2020, Vol. 38 Issue 36, p4260-4273, 15p
- Publication Year :
- 2020
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 38
- Issue :
- 36
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 147642103
- Full Text :
- https://doi.org/10.1200/JCO.19.03250